00460.HK
Sihuan Pharmaceutical Holdings Group Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.71
−2.07%Year over year
Reported trailing growth
- Revenue
- +25.5%
- EBITDA
- +1532.8%
- EBIT
- +3727.4%
- EPS
- +483.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +6.3%
- EBITDA
- +44.9%
- EBIT
- +93.8%
- Net income
- +182.9%
- EPS
- +184.2%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026